Skip to content Skip to Search
Skip navigation

Abu Dhabi puts together global life sciences contender

The UAE and Saudi Arabia in particular are investing heavily in life sciences and longevity Pexels/Tima Miroshnichenko
The UAE and Saudi Arabia in particular are investing heavily in life sciences and longevity
  • Three companies united in umbrella entity
  • Arcera to sell 2,000 branded medicines
  • Sales and distribution in 90 countries

A new company to help establish Abu Dhabi as a major global player in life sciences has been announced by the emirate’s sovereign wealth fund ADQ.

The new concern, called Arcera, will act as an umbrella entity for ADQ’s shareholdings in the Swiss pharmaceutical company Acino, Birgi Mefar Group of Turkey and Egypt’s Amoun.

Arcera will have a workforce of more than 6,500 people and sales and distribution in 90 countries. It will sell 2,000 branded medicines across a wide range of therapeutic areas. 

The company’s manufacturing and packaging base encompasses seven sites in the UAE, Switzerland, Ukraine, Estonia, South Africa, Turkey and Egypt.

Its launch is part of plans to realise Abu Dhabi’s 2030 Healthcare Life Sciences Vision and bolster the UAE’s aspiration to emerge as a frontrunner in science and technology.

ADQ said that Arcera is planning to double its revenue over the next five years through acquisitions and partnerships in key markets.

The longevity sector is estimated to be worth $26 trillion. The analytics company Deep Knowledge Group predicts it will reach $33 trillion by 2026. 

In a study last year by Ageing Analytics Agency, part of Deep Knowledge, the longevity industry in the UAE alone was projected to grow by 8.5 percent annually to $32 billion by 2026.

Isabel Afonso, CEO of Arcera, said: “The growing need for high-quality and effective medicines lends tremendous importance to building a global life sciences company like Arcera.”

In the Middle East, the UAE and Saudi Arabia in particular are investing in health technologies that can predict medical risk and help develop medicines. 

They are putting money into healthtech, building laboratories to support research and development in diagnostics and preventative drugs, and inviting companies and institutions to set up operations in the Gulf.  

Crossing the fields of biotech, pharmaceuticals, fintech, AI and robotics, the longevity sector is about using technology to tackle the so-called diseases of ageing. These ailments – cancer, heart disease and Alzheimer’s – have replaced infectious diseases as humanity’s leading causes of death. 

Last year Saudi Arabia’s sovereign wealth fund, PIF, launched Lifera, a pharmaceutical investment company that will make products including insulins, vaccines and plasma therapeutics. 

Abu Dhabi’s Artificial Intelligence and Advanced Technology Council announced last month the creation of MGX, a technology investment company that has life sciences as one of its focus sectors. The sovereign wealth fund Mubadala and technology group G42 are foundational partners.

In February the Department of Health in Abu Dhabi signed an agreement with GSK, a global biopharma company. Officials said the partnership has “immense potential” to revolutionise the life sciences landscape globally. 

Lina Shadid, health industries leader and a partner at PwC Middle East, said Gulf countries are reacting to demographic changes which pose a potential burden on healthcare systems.

Writing for AGBI, she said by 2025 people over the age of 50 are expected to make up almost one in five of the GCC population, up from one in seven in 2020.

“The private sector in the Gulf must come forward to promote public-private partnerships and support healthy ageing and longevity-related initiatives, policies, and research in the region,” she said.

Latest articles

Over 400 global food brands are taking part in the SaudiFood Manufacturing show in Riyadh this month

Saudi Arabia’s food factory count rises to 1,300

The total number of food factories operated by the Saudi Authority for Industrial Cities and Technology Zones (Modon) has reached 1,300, across 36 cities. The increase signifies the growing capacity of the domestic food industry and its localisation efforts, the state-run Saudi Press Agency reported. Food industry companies have recorded a growth rate of more […]

Garden, Nature, Outdoors

UAE commits $50m to development fund

The UAE has committed $50 million to the second phase of the Lives and Livelihoods Fund 2.0 (LLF 2.0), a multi-donor initiative targeting sustainable economic development in the Islamic Development Bank’s (ISDB) 57 member countries. The funding will be deployed by LLF 2.0 to support critical projects in health and infectious diseases, agriculture, and social infrastructure in low […]

Abu Dhabi’s last debt market activity included a $2 billion bond in May 2021 followed by a further $3 billion in September

Abu Dhabi launches $5bn bond issue

Abu Dhabi has initiated $5 billion in a three-tranche bond after a hiatus of three years, according to a media report. The $1.75 billion five-year bond, $1.5 billion 10-year tranche and $1.75 billion 30-year issue was priced at 35, 45 and 90 basis points, respectively, over US Treasuries, fixed income news service IFR reported. Abu Dhabi […]

A square in Cairo

‘Worst is behind us’ in Egypt’s black market dollar war says BMI

The Egyptian government’s priority for 2024 should be to keep the gap between the official and parallel exchange rates for Egypt’s pound and the US dollar as narrow as possible, says BMI Research. In a webinar on Tuesday BMI, a Fitch Group firm specialised in country risk, said that “the worst is behind us” in […]